PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers

Affiliation auteurs!!!! Error affiliation !!!!
TitrePRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers
Type de publicationJournal Article
Year of Publication2020
AuteursLegoux J.L, Faroux R., Barriere N., Le Malicot K., Tougeron D., Lorgis V., Guerin-Meyer V., Bourgeois V., Malka D., Aparicio T., Baconnier M., Lebrun-Ly V., Egreteau J., F. Akouz K, Lepage C., Boige V.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS430-S431
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.555